{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:17:19Z","timestamp":1790705839818,"version":"4.1.0"},"reference-count":29,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T00:00:00Z","timestamp":1533513600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"DBT-BIRAC","award":["BIRAC\/KIIT0040\/BIG -06\/14"],"award-info":[{"award-number":["BIRAC\/KIIT0040\/BIG -06\/14"]}]},{"name":"Thriveni earthmovers","award":["Personal donation"],"award-info":[{"award-number":["Personal donation"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0201740","type":"journal-article","created":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T13:29:56Z","timestamp":1533562196000},"page":"e0201740","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":18,"title":["Tear biomarkers in latanoprost and bimatoprost treated eyes"],"prefix":"10.1371","volume":"13","author":[{"given":"Shweta","family":"Reddy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prity","family":"Sahay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debananda","family":"Padhy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarada","family":"Sarangi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mrutyunjay","family":"Suar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Modak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8120-8740","authenticated-orcid":true,"given":"Aparna","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,8,6]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/ICU.0000000000000346","article-title":"New classes of glaucoma medications","volume":"28","author":"EM Schehlein","year":"2017","journal-title":"Curr Opin Ophthalmol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"674","DOI":"10.7326\/M15-2367","article-title":"Network Meta-analysis for Clinical Practice Guidelines: A Case Study on First-Line Medical Therapies for Primary Open-Angle Glaucoma","volume":"164","author":"B Rouse","year":"2016","journal-title":"Ann Intern Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"903","DOI":"10.2147\/OPTH.S44708","article-title":"Managing adverse effects of glaucoma medications","volume":"8","author":"K Inoue","year":"2014","journal-title":"Clin Ophthalmol"},{"key":"ref4","first-page":"1690","article-title":"Comparison of the ocular tolerability of a latanoprost cationic emulsion versus conventional formulations of prostaglandins: an in vivo toxicity assay","volume":"15","author":"H Liang","year":"2009","journal-title":"Mol Vis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/bjo.2006.101485","article-title":"Measurement of inflammatory cytokines by multicytokine assay in tears of patients with glaucoma topically treated with chronic drugs","volume":"91","author":"L Malvitte","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"ref6","first-page":"40","article-title":"In Vitro and in Vivo Experimental Studies on Trabecular Meshwork Degeneration Induced by Benzalkonium Chloride (An American Ophthalmological Society Thesis)","volume":"110","author":"C Baudouin","year":"2012","journal-title":"Trans Am Ophthalmol Soc"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/ATVBAHA.110.207449","article-title":"Prostaglandins and Inflammation","volume":"31","author":"E Ricciotti","year":"2011","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1136\/bjophthalmol-2012-303040","article-title":"Bimatoprost 0.03% preservative-free ophthalmic solution versus bimatoprost 0.03% ophthalmic solution (Lumigan) for glaucoma or ocular hypertension: a 12-week, randomised, double-masked trial","volume":"97","author":"DG Day","year":"2013","journal-title":"Br J Ophthalmol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/eye.2013.304","article-title":"Bimatoprost 0.01% <italic>vs<\/italic> bimatoprost 0.03%: a 12-month prospective trial of clinical and <italic>in vivo<\/italic> confocal microscopy in glaucoma patients","volume":"28","author":"M Figus","year":"2014","journal-title":"Eye (Lond)"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1038\/eye.2012.195","article-title":"Adverse periocular reactions to five types of prostaglandin analogs","volume":"26","author":"K Inoue","year":"2012","journal-title":"Eye (Lond)"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3341\/kjo.2015.29.4.270","article-title":"<italic>In Vivo<\/italic> Effects of Preservative-free and Preserved Prostaglandin Analogs: Mouse Ocular Surface Study","volume":"29","author":"JH Kim","year":"2015","journal-title":"Korean J Ophthalmol"},{"issue":"6","key":"ref12","doi-asserted-by":"crossref","first-page":"e0129419","DOI":"10.1371\/journal.pone.0129419","article-title":"Effects of Four Formulations of Prostaglandin Analogs on Eye Surface Cells.A Comparative Study","volume":"10","author":"F P\u00e9rez-Roca","year":"2015","journal-title":"PLoS One"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nrm2125","article-title":"Matrix metalloproteinases and the regulation of tissue remodelling","volume":"8","author":"A Page-McCaw","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.exer.2011.10.017","article-title":"Effect of prostaglandin analogues on tear proteomics and expression of cytokines and matrix metalloproteinases in the conjunctiva and cornea","volume":"94","author":"HY Lopilly Park","year":"2012","journal-title":"Exp Eye Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4103\/0301-4738.151456","article-title":"Decreased keratocyte density and central corneal thickness in primary open-angle glaucoma patients undergoing treatment with topical prostaglandin analogues","volume":"63","author":"S Kocabeyoglu","year":"2015","journal-title":"Indian J Ophthalmol"},{"key":"ref16","first-page":"3147","article-title":"Different cellular effects of four anti-inflammatory eye drops on human corneal epithelial cells: independent in active components","volume":"17","author":"M Qu","year":"2011","journal-title":"Mol Vis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"BIO106","DOI":"10.1167\/iovs.17-21723","article-title":"Functional Activity of Matrix Metalloproteinases 2 and 9 in Tears of Patients with Glaucoma","volume":"58","author":"P Sahay","year":"2017","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"ref18","first-page":"637","article-title":"Prostaglandins, nonsteroidal anti-inflammatory agents and eye disease","volume":"74","author":"SM Podos","year":"1976","journal-title":"Trans Am Ophthalmol Soc"},{"key":"ref19","first-page":"821","article-title":"Effect of benzalkonium chloride-free latanoprost ophthalmic solution on ocular surface in patients withglaucoma","volume":"10","author":"T Walimbe","year":"2016","journal-title":"ClinOphthalmol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3341\/kjo.2013.27.6.446","article-title":"<italic>In Vitro<\/italic> Effects of Preservative-free and Preserved Prostaglandin Analogs on Primary Cultured Human Conjunctival Fibroblast Cells","volume":"27","author":"EJ Kim","year":"2013","journal-title":"Korean J Ophthalmol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12886-016-0202-8","article-title":"Bimatoprost, latanoprost, and tafluprost induce differential expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases","volume":"16","author":"H Yamada","year":"2016","journal-title":"BMC Ophthalmol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2174\/1874364101408010067","article-title":"Ocular surface alterations and topical antiglaucomatous Therapy: A Review","volume":"8","author":"AG Actis","year":"2014","journal-title":"Open Ophthalmol J"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jcjo.2014.10.006","article-title":"Prostaglandin agonist effect on matrix metalloproteinase aqueous levels in glaucoma patients","volume":"50","author":"Z S Pradhan","year":"2015","journal-title":"Can J Ophthalmol"},{"key":"ref24","first-page":"577","article-title":"The Biology, Pathology and Therapeutic Use of Prostaglandins in the Eye","volume":"6","author":"CB Toris","year":"2011","journal-title":"ClinLipidology"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1001\/archophthalmol.2010.40","article-title":"Effect of latanoprost on the expression of matrix metalloproteinases and tissue inhibitor of metalloproteinase 1 on the ocular surface","volume":"128","author":"N Honda","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"ref26","first-page":"155","article-title":"Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy","volume":"17","author":"AM Abu El-Asrar","year":"2006","journal-title":"Eur Cytokine Netw"},{"key":"ref27","first-page":"352","article-title":"Aqueous humor cytokine profiling in patients with wet AMD","volume":"22","author":"F Liu","year":"2016","journal-title":"Mol Vis"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1159\/000150445","article-title":"Inflammatory markers in the tears of patients with ocular surface disease","volume":"40","author":"A Acera","year":"2008","journal-title":"Ophthalmic Res"},{"key":"ref29","first-page":"17","article-title":"The role of CC-Chemokines in the Regulation of angiogenesis","volume":"8","author":"A Ridiandries","year":"2016","journal-title":"Int J Mol Sci"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0201740","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T18:22:34Z","timestamp":1571682154000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0201740"}},"subtitle":[],"editor":[{"given":"Andrew W.","family":"Taylor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,8,6]]},"references-count":29,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2018,8,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0201740","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,6]]}}}